Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Non-Peptide Drugs of Angiotensin II Receptor Antagonist industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Mylan
Boehringer Ingelheim
Alembic Pharmaceuticals
AstraZeneca
Novartis
Shenzhen Salubris Pharmaceuticals
Jhonson and Johnson
GSK
Lupin
Bayer
Pfizer
Merck
Amneal Pharmaceuticals
Bristol-Myers Squibb
Eli Lilly
Teva Pharmaceutical
Aurobindo Pharma
Sun Pharmaceutical
Sanofi
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Valsartan
Irbesartan
Candesartan Cilexetil
Eprosartan
Irbesartan
Telmisartan
losartan
Olmesartan Medoxomil
Allisartan isoproxil
Application:
High Blood Pressure
Congestive Heart Failure
Left Ventricular Hypertrophy
Atherosclerosis
Other
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Industry Overview
-
1.1.1 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Scope and Market Segments
-
1.1.2 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Industry Characteristics
-
1.1.3 Global and China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Production Value and Growth Rate (2017-2028)
-
1.2 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Valsartan
-
1.2.2 Irbesartan
-
1.2.3 Candesartan Cilexetil
-
1.2.4 Eprosartan
-
1.2.5 Irbesartan
-
1.2.6 Telmisartan
-
1.2.7 losartan
-
1.2.8 Olmesartan Medoxomil
-
1.2.9 Allisartan isoproxil
-
1.3 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 High Blood Pressure
-
1.3.2 Congestive Heart Failure
-
1.3.3 Left Ventricular Hypertrophy
-
1.3.4 Atherosclerosis
-
1.3.5 Other
-
1.4 Market Analysis by Region
-
1.4.1 North America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Non-Peptide Drugs of Angiotensin II Receptor Antagonist Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Non-Peptide Drugs of Angiotensin II Receptor Antagonist Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Non-Peptide Drugs of Angiotensin II Receptor Antagonist Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Industry Porter's Five Forces Model Analysis
-
2.2.3 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Industry PEST Analysis
-
2.3 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Non-Peptide Drugs of Angiotensin II Receptor Antagonist Industry
Chapter 3 Global and China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market, by Manufacturer
-
3.1 Global and China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Top 3 Players
Chapter 4 Global and China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market, by Type (2017-2028)
-
4.1 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Trend, by Type
-
4.2 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Price Trend, by Type (2017-2028)
-
4.3 China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Price Trend, by Type (2017-2028)
Chapter 5 Global and China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Non-Peptide Drugs of Angiotensin II Receptor Antagonist Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Non-Peptide Drugs of Angiotensin II Receptor Antagonist Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Non-Peptide Drugs of Angiotensin II Receptor Antagonist Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Analysis
-
7.1 North America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market, by Type
-
7.2 North America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market, by Application
-
7.3 North America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Analysis and Forecast, by Country
-
7.3.1 United States Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Analysis
-
8.1 Europe Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market, by Type
-
8.2 Europe Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market, by Application
-
8.3 Europe Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Analysis and Forecast, by Country
-
8.3.1 Germany Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Analysis
-
9.1 APAC Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market, by Type
-
9.2 APAC Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market, by Application
-
9.3 APAC Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Analysis and Forecast, by Country
-
9.3.1 China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Analysis
-
10.1 Latin America, Middle East and Africa Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market, by Type
-
10.2 Latin America, Middle East and Africa Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market, by Application
-
10.3 Latin America, Middle East and Africa Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Company Profiles
-
11.1 Mylan
-
11.1.1 Mylan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Mylan Non-Peptide Drugs of Angiotensin II Receptor Antagonist Product Profiles, Application and Specification
-
11.1.3 Mylan Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Boehringer Ingelheim
-
11.2.1 Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Boehringer Ingelheim Non-Peptide Drugs of Angiotensin II Receptor Antagonist Product Profiles, Application and Specification
-
11.2.3 Boehringer Ingelheim Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Alembic Pharmaceuticals
-
11.3.1 Alembic Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Alembic Pharmaceuticals Non-Peptide Drugs of Angiotensin II Receptor Antagonist Product Profiles, Application and Specification
-
11.3.3 Alembic Pharmaceuticals Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 AstraZeneca
-
11.4.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 AstraZeneca Non-Peptide Drugs of Angiotensin II Receptor Antagonist Product Profiles, Application and Specification
-
11.4.3 AstraZeneca Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Novartis
-
11.5.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Novartis Non-Peptide Drugs of Angiotensin II Receptor Antagonist Product Profiles, Application and Specification
-
11.5.3 Novartis Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Shenzhen Salubris Pharmaceuticals
-
11.6.1 Shenzhen Salubris Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Shenzhen Salubris Pharmaceuticals Non-Peptide Drugs of Angiotensin II Receptor Antagonist Product Profiles, Application and Specification
-
11.6.3 Shenzhen Salubris Pharmaceuticals Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Jhonson and Johnson
-
11.7.1 Jhonson and Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Jhonson and Johnson Non-Peptide Drugs of Angiotensin II Receptor Antagonist Product Profiles, Application and Specification
-
11.7.3 Jhonson and Johnson Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 GSK
-
11.8.1 GSK Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 GSK Non-Peptide Drugs of Angiotensin II Receptor Antagonist Product Profiles, Application and Specification
-
11.8.3 GSK Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Lupin
-
11.9.1 Lupin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Lupin Non-Peptide Drugs of Angiotensin II Receptor Antagonist Product Profiles, Application and Specification
-
11.9.3 Lupin Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Bayer
-
11.10.1 Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Bayer Non-Peptide Drugs of Angiotensin II Receptor Antagonist Product Profiles, Application and Specification
-
11.10.3 Bayer Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 Pfizer
-
11.11.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 Pfizer Non-Peptide Drugs of Angiotensin II Receptor Antagonist Product Profiles, Application and Specification
-
11.11.3 Pfizer Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 Merck
-
11.12.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 Merck Non-Peptide Drugs of Angiotensin II Receptor Antagonist Product Profiles, Application and Specification
-
11.12.3 Merck Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.13 Amneal Pharmaceuticals
-
11.13.1 Amneal Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.13.2 Amneal Pharmaceuticals Non-Peptide Drugs of Angiotensin II Receptor Antagonist Product Profiles, Application and Specification
-
11.13.3 Amneal Pharmaceuticals Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.14 Bristol-Myers Squibb
-
11.14.1 Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.14.2 Bristol-Myers Squibb Non-Peptide Drugs of Angiotensin II Receptor Antagonist Product Profiles, Application and Specification
-
11.14.3 Bristol-Myers Squibb Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.15 Eli Lilly
-
11.15.1 Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.15.2 Eli Lilly Non-Peptide Drugs of Angiotensin II Receptor Antagonist Product Profiles, Application and Specification
-
11.15.3 Eli Lilly Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.16 Teva Pharmaceutical
-
11.16.1 Teva Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.16.2 Teva Pharmaceutical Non-Peptide Drugs of Angiotensin II Receptor Antagonist Product Profiles, Application and Specification
-
11.16.3 Teva Pharmaceutical Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.17 Aurobindo Pharma
-
11.17.1 Aurobindo Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.17.2 Aurobindo Pharma Non-Peptide Drugs of Angiotensin II Receptor Antagonist Product Profiles, Application and Specification
-
11.17.3 Aurobindo Pharma Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.18 Sun Pharmaceutical
-
11.18.1 Sun Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.18.2 Sun Pharmaceutical Non-Peptide Drugs of Angiotensin II Receptor Antagonist Product Profiles, Application and Specification
-
11.18.3 Sun Pharmaceutical Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.19 Sanofi
-
11.19.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.19.2 Sanofi Non-Peptide Drugs of Angiotensin II Receptor Antagonist Product Profiles, Application and Specification
-
11.19.3 Sanofi Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Industry Investment Prospect and Risk Assessment
-
12.1 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Growth Rate (2017-2028)
-
Figure China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Growth Rate (2017-2028)
-
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Production Value and Growth Rate (2017-2028)
-
Figure China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Production Value and Growth Rate (2017-2028)
-
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Size and Growth Rate of Valsartan (2017-2028)
-
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Size and Growth Rate of Irbesartan (2017-2028)
-
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Size and Growth Rate of Candesartan Cilexetil (2017-2028)
-
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Size and Growth Rate of Eprosartan (2017-2028)
-
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Size and Growth Rate of Irbesartan (2017-2028)
-
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Size and Growth Rate of Telmisartan (2017-2028)
-
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Size and Growth Rate of losartan (2017-2028)
-
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Size and Growth Rate of Olmesartan Medoxomil (2017-2028)
-
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Size and Growth Rate of Allisartan isoproxil (2017-2028)
-
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Size and Growth Rate of High Blood Pressure (2017-2028)
-
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Size and Growth Rate of Congestive Heart Failure (2017-2028)
-
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Size and Growth Rate of Left Ventricular Hypertrophy (2017-2028)
-
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Size and Growth Rate of Atherosclerosis (2017-2028)
-
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Size and Growth Rate of Other (2017-2028)
-
Figure North America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Non-Peptide Drugs of Angiotensin II Receptor Antagonist Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Non-Peptide Drugs of Angiotensin II Receptor Antagonist Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Non-Peptide Drugs of Angiotensin II Receptor Antagonist Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Share, by Manufacturer in 2021
-
Figure Global and China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Share, by Manufacturer in 2022
-
Table Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, by Type (2017-2028)
-
Table Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume Share, by Type (2017-2028)
-
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume Share, by Type (2017-2028)
-
Table Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value, by Type (2017-2028)
-
Table Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value Share, by Type (2017-2028)
-
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Price Trend, by Type (2017-2028)
-
Table China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, by Type (2017-2028)
-
Table China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume Share, by Type (2017-2028)
-
Figure China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume Share, by Type (2017-2028)
-
Table China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value, by Type (2017-2028)
-
Table China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value Share, by Type (2017-2028)
-
Figure China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Price Trend, by Type (2017-2028)
-
Table Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, by Application (2017-2028)
-
Table Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume Share, by Application (2017-2028)
-
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume Share, by Application (2017-2028)
-
Table Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value, by Application (2017-2028)
-
Table Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value Share, by Application (2017-2028)
-
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value Share, by Application (2017-2028)
-
Table China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, by Application (2017-2028)
-
Table China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume Share, by Application (2017-2028)
-
Figure China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume Share, by Application (2017-2028)
-
Table China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value, by Application (2017-2028)
-
Table China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value Share, by Application (2017-2028)
-
Figure China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value Share, by Application (2017-2028)
-
Figure China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Production, Import, Consumption and Export (2017-2022)
-
Figure North America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Non-Peptide Drugs of Angiotensin II Receptor Antagonist Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Non-Peptide Drugs of Angiotensin II Receptor Antagonist Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Non-Peptide Drugs of Angiotensin II Receptor Antagonist Production, Import, Consumption and Export (2017-2022)
-
Table North America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, by Type (2017-2028)
-
Table North America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume Share, by Type (2017-2028)
-
Figure North America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume Share, by Type (2017-2028)
-
Table North America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, by Application (2017-2028)
-
Table North America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume Share, by Application (2017-2028)
-
Figure North America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume Share, by Application (2017-2028)
-
Figure United States Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Growth Rate (2017-2028)
-
Figure United States Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value and Growth Rate (2017-2028)
-
Figure Canada Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value and Growth Rate (2017-2028)
-
Table Europe Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, by Type (2017-2028)
-
Table Europe Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume Share, by Type (2017-2028)
-
Figure Europe Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume Share, by Type (2017-2028)
-
Table Europe Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, by Application (2017-2028)
-
Table Europe Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume Share, by Application (2017-2028)
-
Figure Europe Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume Share, by Application (2017-2028)
-
Figure Germany Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value and Growth Rate (2017-2028)
-
Figure UK Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Growth Rate (2017-2028)
-
Figure UK Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value and Growth Rate (2017-2028)
-
Figure France Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Growth Rate (2017-2028)
-
Figure France Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value and Growth Rate (2017-2028)
-
Figure Italy Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value and Growth Rate (2017-2028)
-
Figure Spain Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value and Growth Rate (2017-2028)
-
Figure Poland Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value and Growth Rate (2017-2028)
-
Figure Russia Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value and Growth Rate (2017-2028)
-
Table APAC Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, by Type (2017-2028)
-
Table APAC Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume Share, by Type (2017-2028)
-
Figure APAC Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume Share, by Type (2017-2028)
-
Table APAC Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, by Application (2017-2028)
-
Table APAC Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume Share, by Application (2017-2028)
-
Figure APAC Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume Share, by Application (2017-2028)
-
Figure China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Growth Rate (2017-2028)
-
Figure China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value and Growth Rate (2017-2028)
-
Figure Japan Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value and Growth Rate (2017-2028)
-
Figure India Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Growth Rate (2017-2028)
-
Figure India Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Value and Growth Rate (2017-2028)
-
Table Mylan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Mylan Product Profiles, Application and Specification
-
Table Mylan Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Boehringer Ingelheim Product Profiles, Application and Specification
-
Table Boehringer Ingelheim Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Alembic Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Alembic Pharmaceuticals Product Profiles, Application and Specification
-
Table Alembic Pharmaceuticals Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table AstraZeneca Product Profiles, Application and Specification
-
Table AstraZeneca Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis Product Profiles, Application and Specification
-
Table Novartis Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Shenzhen Salubris Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Shenzhen Salubris Pharmaceuticals Product Profiles, Application and Specification
-
Table Shenzhen Salubris Pharmaceuticals Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Jhonson and Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Jhonson and Johnson Product Profiles, Application and Specification
-
Table Jhonson and Johnson Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table GSK Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table GSK Product Profiles, Application and Specification
-
Table GSK Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Lupin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Lupin Product Profiles, Application and Specification
-
Table Lupin Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bayer Product Profiles, Application and Specification
-
Table Bayer Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Pfizer Product Profiles, Application and Specification
-
Table Pfizer Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Merck Product Profiles, Application and Specification
-
Table Merck Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Amneal Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Amneal Pharmaceuticals Product Profiles, Application and Specification
-
Table Amneal Pharmaceuticals Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bristol-Myers Squibb Product Profiles, Application and Specification
-
Table Bristol-Myers Squibb Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Eli Lilly Product Profiles, Application and Specification
-
Table Eli Lilly Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Teva Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Teva Pharmaceutical Product Profiles, Application and Specification
-
Table Teva Pharmaceutical Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Aurobindo Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Aurobindo Pharma Product Profiles, Application and Specification
-
Table Aurobindo Pharma Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sun Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sun Pharmaceutical Product Profiles, Application and Specification
-
Table Sun Pharmaceutical Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sanofi Product Profiles, Application and Specification
-
Table Sanofi Non-Peptide Drugs of Angiotensin II Receptor Antagonist Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
